When we compared the 2 groups in the study, we found them to be well-matched, with no significant differences in demographic or preoperative clinical characteristics (including tumor size or number, as well as baseline hepatitis, comorbidity, or AFP levels), or in type of hepatectomy performed, histopathological evidence of cirrhosis, or postoperative complications. This evidence concerns the gene AFP and hepatitis A virus infection.